31 October 2017

Interrad Medical, Inc.

LGB is acting as the European placement agent in the $7 million offering of secured convertible notes by Interrad Medical, Inc. (www.securacath.com). 

The company has developed a platform technology for the stabilisation of catheters using a sub-cutaneous anchor. The UK's NICE issued guidance in favour of the use of its lead product, SecurAcath, in June. More than $5 million of notes have been issued so far. 

Recent Articles

10 November 2020

MPE Properties Ltd. redeems loan notes in full

In March 2015, MPE Properties Ltd raised £1,050,000 through the issue of medium term notes under the terms of a loan note programme arranged by LGB.

Read more

9 November 2020

FTSE100 rockets as investors see light at the end of the lockdown tunnel

Andrew Boyle, CEO of LGB & Co., commented in a ProActive Investors piece on the Pfizer vaccine announcement. 
 

Read more

News & Insights

3 November 2020

Pre-election IPO rush set to slow in Europe, Asia

Ivan Sedgwick, Investment Director at LGB & Co., contributed to an article on Bloomberg on the impact on IPOs in the run up to the US presidential election.

Read more

News & Insights